Usual Blood Pressure and Risk of New-Onset Diabetes Evidence from 4.1 Million Adults and a Meta-Analysis of Prospective Studies

Journal of the American College of Cardiology

Volumn 66, Issue 14, 2015, Pages 1552-1562

  Emdin, Connor A ^a   Anderson, Simon G ^a,b   Woodward, Mark ^a,c   Rahimi, Kazem ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

body mass index; meta analysis; regression dilution bias

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; AGE; AGED; BLOOD PRESSURE; COMPLICATION; DIABETES MELLITUS, TYPE 2; HYPERTENSION; INCIDENCE; META ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; UNITED KINGDOM;

EID: 84942693222     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.07.059     Document Type: Article

References (33)

1. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract 94 2011 311 321
2. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular risk factors: the Framingham study Circulation 59 1979 8 13
3. K.S. Taylor, C.J. Heneghan, A.J. Farmer, and et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database Diabetes Care 36 2013 2366 2371
4. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
5. B. Chamarthi, G.H. Williams, V. Ricchiuti, and et al. Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans Am J Hypertens 24 2011 1143 1148
6. S. Taddei, A. Virdis, L. Ghiadoni, I. Sudano, and A. Salvetti Antihypertensive drugs and reversing of endothelial dysfunction in hypertension Curr Hypertens Rep 2 2000 64 70
7. Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis Lancet 379 2012 1214 1224
8. J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
9. D. Conen, P.M. Ridker, S. Mora, J.E. Buring, and R.J. Glynn Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study Eur Heart J 28 2007 2937 2943
10. E. Herrett, A.D. Shah, R. Boggon, and et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study BMJ 346 2013 f2350
11. E. Herrett, S.L. Thomas, W.M. Schoonen, L. Smeeth, and A.J. Hall Validation and validity of diagnoses in the General Practice Research Database: a systematic review Br J Clin Pharmacol 69 2010 4 14
12. N. Hex, C. Bartlett, D. Wright, M. Taylor, and D. Varley Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs Diabet Med 29 2012 855 862
13. D.F. Easton, J. Peto, and A.G. Babiker Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group Stat Med 10 1991 1025 1035
14. D. Wormser, I.R. White, S.G. Thompson, and A.M. Wood Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease Int J Epidemiol 42 2013 849 859
15. Emerging Risk Factors Collaboration S. Erqou, S. Kaptoge, P.L. Perry, and et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
16. Emerging Risk Factors Collaboration N. Sarwar, P. Gao, S.R. Seshasai, and et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2010 2215 2222
17. Emerging Risk Factors Collaboration S. Kaptoge, E. Di Angelantonio, G. Lowe, and et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
18. Prospective Studies Collaboration S. Lewington, G. Whitlock, R. Clarke, and et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Lancet 370 2007 1829 1839
19. P.M. Ridker, A. Pradhan, J.G. MacFadyen, P. Libby, and R.J. Glynn Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Lancet 380 2012 565 571
20. W.J. Elliott, and P.M. Meyer Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis Lancet 369 2007 201 207
21. I.J. Perry, S.G. Wannamethee, M.K. Walker, A.G. Thomson, P.H. Whincup, and A.G. Shaper Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men BMJ 310 1995 560 564
22. Prospective Studies Collaboration G. Whitlock, S. Lewington, P. Sherliker, and et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet 373 2009 1083 1096
23. M. Chihaoui, F. Kanoun, B. Ben Rehaiem, and et al. Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population Diabetes Metab 27 2001 487 495
24. S.S. Sawada, I.M. Lee, H. Naito, and et al. Long-term trends in cardiorespiratory fitness and the incidence of type 2 diabetes Diabetes Care 33 2010 1353 1357
25. C.M. Burchfiel, J.D. Curb, B.L. Rodriguez, and et al. Incidence and predictors of diabetes in Japanese-American men. The Honolulu Heart Program Ann Epidemiol 5 1995 33 43
26. L.H. Lindholm, H. Ibsen, K. Borch-Johnsen, and et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study J Hypertens 20 2002 1879 1886
27. R. Cooper-DeHoff, J.D. Cohen, G.L. Bakris, and et al. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]) Am J Cardiol 98 2006 890 894
28. J.J. McMurray, R.R. Holman, S.M. Haffner, et al. for the NAVIGATOR Study Group Effect of valsartan on the incidence of diabetes and cardiovascular events N Engl J Med 362 2010 1477 1490
29. B.L. Carter, P.T. Einhorn, M. Brands, and et al. Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute Hypertension 52 2008 30 36
30. A.D. Pradhan, J.E. Manson, N. Rifai, and et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
31. P. Dandona, A. Aljada, and A. Bandyopadhyay Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 2004 4 7
32. P.M. Ridker, E. Danielson, N. Rifai, and R.J. Glynn Val-MARC Investigators. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial Hypertension 48 2006 73 79
33. T.-P. Van Staa, and L. Abenhaim The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions Pharmacoepidem Drug Safe 3 1994 15 21